Navigation Links
Charles Hauser, John Vann named to PMG Research Board of Directors
Date:8/7/2014

Winston-Salem, NC (PRWEB) August 07, 2014

PMG Research, Inc. announced today the election of its Board of Directors. Charles Hauser, CEO of Piedmont Stone Center, and John Vann, a business management consultant at The Summit Companies, will join Jennifer Byrne, Chairman of the Board and CEO of PMG Research, and Joel Lanik, Partner at Frontier Capital, as Directors on PMG Research Board.

PMG Research is a network of sites that provide clinical research services to pharmaceutical companies and CROs, with access to 1.7 million patient lives through its partnerships with large physician practices and integrated health systems. PMG Research is comprised of 10 hub site locations in the Southeastern United States and spans 53 physician practices.

“I am pleased to be a member of the PMG Research Board of Directors,” states Charles Hauser. “I look forward to the opportunity to continue to support PMG’s vision and drive for innovation within the clinical trials industry.” From 1980 to 2006, Mr. Hauser was the President and co-founder of Piedmont Medical Research Associates, now PMG Research. He has served on numerous corporate and community Boards, including the State Health Coordinating Council and the North Carolina Medical Care Commission.

John Vann has extensive experience in the clinical research industry, having co-founded Clinical Trial Management Services (CTMS) followed by several years in corporate development with a leading UK-based CRO. “I look forward to participating on the Board of PMG Research. PMG has a reputation for quality and experience, with a strong focus on patient engagement and strategic development that will help define the new landscape in clinical research,” explains Mr. Vann.

“We are grateful for the participation of Mr. Hauser and Mr. Vann on our Board of Directors. They bring an immense breadth of experience and insight, and their guidance will prove valuable as PMG continues to find innovative ways to partner with healthcare, pharma, and CROs to achieve our mission: bringing clinical research to as many lives as possible,” states Jennifer Byrne.

About PMG Research, Inc.
PMG Research, Inc. is an integrated network of clinical research facilities with hub sites located in Cary, Charlotte, Hickory, Raleigh, Salisbury, Wilmington, and Winston-Salem, NC; Charleston, SC; and Bristol and Knoxville, TN. PMG has conducted 7,100 research studies for hundreds of pharmaceutical sponsors and CROs since 1979. We have extensive experience conducting all phases of trials across a comprehensive list of conditions. Our mission is to bring clinical research to as many lives as possible while delivering unparalleled service and exceptional value to our clinical trial partners and stakeholders. To learn more, visit http://www.pmg-research.com.

Read the full story at http://www.prweb.com/releases/2014/08/prweb12076432.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Professor Charles Lieber receives Israels Wolf Prize
2. EMD Millipore Partners with Charles River Laboratories for Improved Viral Clearance Studies
3. BioMed Realty Acquires 320 Charles In Cambridge, MA
4. Elsevier Announces 2013 Library Connect Charleston Conference Award
5. Cleveland Heart Founder Dr. Charles Richardson Appointed to ReliantHeart Board of Directors
6. Charles M. Lieber receives the first Nano Research Award
7. Callibra, Inc. dba Discharge 1-2-3 is Named Winner of 2011 Chicago Innovation Award
8. Dr. Alice Jacobs, CEO of IntelligentMDx, Named Best Entrepreneur in Eighth Annual Stevie® Awards for Women in Business
9. Sequenom Named to NASDAQ Global Select Market
10. U of Toronto experiment named top breakthrough of 2011 by Physics World
11. BioStorage Technologies Mike Reffeitt Named "CFO of the Year" by Indianapolis Business Journal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published today ... a patient who developed lymphedema after being treated for breast cancer benefitted from an ... paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
(Date:6/23/2016)... 23, 2016 On Wednesday, June 22, ... down 0.22%; the Dow Jones Industrial Average edged 0.27% lower ... 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on the following ... Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... BIND ). Learn more about these stocks by accessing ...
(Date:6/23/2016)... SAN FRANCISCO , June 22, 2016  Amgen ... platinum sponsorship of the QB3@953 life sciences ... improve human health. The shared laboratory space at QB3@953 ... startups overcome a key obstacle for many early stage ... As part of the sponsorship, Amgen launched two "Amgen ...
Breaking Biology Technology:
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
(Date:4/26/2016)... LONDON , April 26, 2016 /PRNewswire/ ... Systems, a product subsidiary of Infosys (NYSE: ... partnership to integrate the Onegini mobile security platform ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration ... security to access and transact across channels. Using ...
(Date:4/19/2016)... The new GEZE SecuLogic access ... "all-in-one" system solution for all door components. It can ... door interface with integration authorization management system, and thus ... minimal dimensions of the access control and the optimum ... offer considerable freedom of design with regard to the ...
Breaking Biology News(10 mins):